{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:28:39Z","timestamp":1783114119996,"version":"3.54.6"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["ZYGD23020"],"award-info":[{"award-number":["ZYGD23020"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2025ZNSFSC0688"],"award-info":[{"award-number":["2025ZNSFSC0688"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2025ZNSFSC1726"],"award-info":[{"award-number":["2025ZNSFSC1726"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M752280"],"award-info":[{"award-number":["2024M752280"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFF1204905"],"award-info":[{"award-number":["2023YFF1204905"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22507084"],"award-info":[{"award-number":["22507084"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2221004"],"award-info":[{"award-number":["T2221004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118380","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T16:37:30Z","timestamp":1763656650000},"page":"118380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P3","title":["Discovery of benzothiazole derivatives as novel orally receptor-interacting protein kinase 1 (RIPK1) inhibitors for inflammatory disease therapy"],"prefix":"10.1016","volume":"302","author":[{"given":"Chufeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghai","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingrui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taijin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8076-163X","authenticated-orcid":false,"given":"Lijuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118380_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nature13706","article-title":"RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis","volume":"513","author":"Takahashi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118380_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","article-title":"Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes","volume":"114","author":"Micheau","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118380_bib3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/SHK.0b013e31820b2db1","article-title":"The dual functions of receptor interacting protein 1 in fas-induced hepatocyte death during sepsis","volume":"35","author":"McNeal","year":"2011","journal-title":"Shock"},{"key":"10.1016\/j.ejmech.2025.118380_bib4","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/cdd.2012.90","article-title":"TRAIL induces necroptosis involving RIPK1\/RIPK3-dependent PARP-1 activation","volume":"19","author":"Jouan-Lanhouet","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2025.118380_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.immuni.2016.06.007","article-title":"RIPK1 and RIPK3 kinases promote cell-death-independent inflammation by toll-like receptor 4","volume":"45","author":"Najjar","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2025.118380_bib6","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1126\/science.1071924","article-title":"TNF-R1 signaling: a beautiful pathway","volume":"296","author":"Chen","year":"2002","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ejmech.2025.118380_bib7","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.cub.2007.01.027","article-title":"Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling","volume":"17","author":"O'Donnell","year":"2007","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejmech.2025.118380_bib8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2008.03.036","article-title":"TNF-alpha induces two distinct caspase-8 activation pathways","volume":"133","author":"Wang","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118380_bib9","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41556-022-00879-y","article-title":"RIPK1 and RIPK3 form mosaic necrosomes","volume":"24","author":"Qi","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118380_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","article-title":"Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3","volume":"54","author":"Wang","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2025.118380_bib11","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.celrep.2015.02.052","article-title":"Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1","volume":"10","author":"Najjar","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2025.118380_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2013.02.003","article-title":"Necroptosis: the release of damage-associated molecular patterns and its physiological relevance","volume":"38","author":"Kaczmarek","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2025.118380_bib13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41573-020-0071-y","article-title":"Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target","volume":"19","author":"Mifflin","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118380_bib14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrm3683","article-title":"Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death","volume":"14","author":"Ofengeim","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118380_bib15","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3389\/fimmu.2020.01318","article-title":"Glucocorticoids in sepsis: to be or not to be","volume":"11","author":"Vandewalle","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.118380_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00003246-199601000-00026","article-title":"Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation","volume":"24","author":"Bone","year":"1996","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejmech.2025.118380_bib17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41419-025-07754-2","article-title":"FDA-approved phensuximide inhibits RIPK1-dependent immunogenic cell death","volume":"16","author":"Kim","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2025.118380_bib18","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1172\/JCI96147","article-title":"RIP kinase 1-dependent endothelial necroptosis underlies systemic inflammatory response syndrome","volume":"128","author":"Zelic","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.118380_bib19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"van Loo","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2025.118380_bib20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s13555-024-01097-0","article-title":"Inhibition of receptor-interacting protein kinase 1 in chronic plaque psoriasis: a multicenter, randomized, double-blind, placebo-controlled study","volume":"14","author":"Ludbrook","year":"2024","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.ejmech.2025.118380_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41419-020-2328-0","article-title":"Inhibition of keratinocyte necroptosis mediated by RIPK1\/RIPK3\/MLKL provides a protective effect against psoriatic inflammation","volume":"11","author":"Duan","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2025.118380_bib22","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood.2022017262","article-title":"A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis","volume":"141","author":"Yu","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2025.118380_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tips.2020.01.002","article-title":"Inhibitors targeting RIPK1\/RIPK3: old and new drugs","volume":"41","author":"Martens","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2025.118380_bib24","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1021\/acs.jmedchem.6b01751","article-title":"Discovery of a first-in-class receptor interacting protein 1 (RIP1) kinase specific clinical candidate (GSK2982772) for the treatment of inflammatory diseases","volume":"60","author":"Harris","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118380_bib25","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/cpt.1615","article-title":"DNL104, a centrally penetrant RIPK1 inhibitor, inhibits RIP1 kinase phosphorylation in a randomized phase I ascending dose study in healthy volunteers","volume":"107","author":"Grievink","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2025.118380_bib26","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/cts.13317","article-title":"Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: randomized, placebo-controlled, double-blind phase I\/Ib studies in healthy subjects and patients","volume":"15","author":"Vissers","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.ejmech.2025.118380_bib27","doi-asserted-by":"crossref","first-page":"31752","DOI":"10.1039\/D5RA04254B","article-title":"Benzothiazole-thiazole hybrids as broad-spectrum antimicrobial agents: synthesis, SAR analysis, and molecular docking against bacterial and fungal targets","volume":"15","author":"Bhagwat","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.118380_bib28","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/j.cclet.2021.09.059","article-title":"Structure-based optimizations of a necroptosis inhibitor (SZM594) as novel protective agents of acute lung injury","volume":"33","author":"Xu","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118380_bib29","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1021\/acs.jmedchem.3c00197","article-title":"Targeting receptor-interacting protein kinase 1 by novel benzothiazole derivatives: treatment of acute lung injury through the necroptosis pathway","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118380_bib30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41419-019-1735-6","article-title":"Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis","volume":"10","author":"Hou","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2025.118380_bib31","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1021\/acs.jmedchem.3c02102","article-title":"From hit to lead: structure-based optimization of novel selective inhibitors of receptor-interacting protein kinase 1 (RIPK1) for the treatment of inflammatory diseases","volume":"67","author":"Zhang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118380_bib32","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.1038\/s41467-022-34692-w","article-title":"Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118380_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116076","article-title":"Discovery of 4-amino-1,6-dihydro-7H-pyrrolo[2,3-d]pyridazin-7-one derivatives as potential receptor-interacting serine\/threonine-protein kinase 1 (RIPK1) inhibitors","volume":"265","author":"Zhang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118380_bib34","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.3390\/biomedicines13071747","article-title":"Necroptotic and apoptotic pathways in sepsis: a comparative analysis of pediatric and adult ICU patients","volume":"13","author":"Briassoulis","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2025.118380_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106697","article-title":"Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis","volume":"189","author":"Shi","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.118380_bib36","doi-asserted-by":"crossref","first-page":"eadf8366","DOI":"10.1126\/scitranslmed.adf8366","article-title":"Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effects","volume":"15","author":"Prado-Acosta","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2025.118380_bib37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1167\/iovs.65.10.38","article-title":"The necroptosis pathway is upregulated in the cornea in mice with ocular graft-versus-host disease","volume":"65","author":"Asai","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejmech.2025.118380_bib38","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1182\/blood.2022019019","article-title":"A novel RIPK1 inhibitor attenuates GVHD","volume":"141","author":"Hill","year":"2023","journal-title":"Blood"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:20:26Z","timestamp":1773818426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425011456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":38,"alternative-id":["S0223523425011456"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118380","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of benzothiazole derivatives as novel orally receptor-interacting protein kinase 1 (RIPK1) inhibitors for inflammatory disease therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118380"}}